MARKET

DAWN

DAWN

Day One Biopharmaceuticals, Inc.
NASDAQ
21.28
+0.08
+0.35%
Opening 10:03 03/09 EDT
OPEN
21.20
PREV CLOSE
21.20
HIGH
21.30
LOW
21.19
VOLUME
2.49M
TURNOVER
--
52 WEEK HIGH
21.30
52 WEEK LOW
5.64
MARKET CAP
2.18B
P/E (TTM)
-20.4587
1D
5D
1M
3M
1Y
5Y
1D
Day One Biopharm Cut to Neutral From Outperform by Wedbush
Dow Jones · 5h ago
Wedbush Downgrades Day One Biopharmaceutical to Neutral, Lowers Price Target to $21.5
Benzinga · 5h ago
Weekly Report: what happened at DAWN last week (0302-0306)?
Weekly Report · 8h ago
U.S. RESEARCH ROUNDUP-Dow, Oracle, Shopify
Reuters · 10h ago
DAY ONE BIOPHARMACEUTICALS INC <DAWN.O>: TD COWEN CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $21.5 FROM $24
Reuters · 12h ago
Day One Biopharma Earnings Call Highlights Ojemda Surge
TipRanks · 1d ago
Key deals this week: Diana Shipping, Day One Biopharmaceuticals, Hudbay Minerals and more
Seeking Alpha · 1d ago
Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions
The Motley Fool · 2d ago
More
About DAWN
Day One Biopharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing targeted therapies for people of all ages with life-threatening diseases. It partners with clinical oncologists, families, and scientists to identify, acquire, and develop cancer treatments. Its commercial product, OJEMDA (tovorafenib), is an oral, brain-penetrant, selective type II rapidly accelerated fibrosarcoma (RAF) kinase inhibitor. OJEMDA is used for the treatment of patients over six months of age and older with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation. Its pipeline product candidates include DAY301 and Emi-Le (emiltatug ledadotin). DAY301 is a novel Antibody Drug Conjugate, or ADC, targeting protein-tyrosine kinase 7, or PTK7. Emi-Le (emiltatug ledadotin) is a novel antibody drug conjugate (ADC) targeting the B7-H4 protein in clinical development to treat the rare cancer adenoid cystic carcinoma (ACC).

Webull offers Day One Biopharmaceuticals Inc stock information, including NASDAQ: DAWN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DAWN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DAWN stock methods without spending real money on the virtual paper trading platform.